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A commentary on
A BK (Slo1) channel journey frommolecule to physiology
by Contreras, G. F., Castillo, K., Enrique, N., Carrasquel-Ursulaez, W., Castillo, J. P., Milesi, V., et al.
(2013). Channels (Austin.) 7, 442–458. doi: 10.4161/chan.26242
Prof. Ramon Latorre of Centro Interdisciplinario de Neurociencia de Valparaíso, Facultad de
Ciencias, Universidad de Valparaíso, Chile, and co-authors in their review paper deal with the
hallmarks of big Ca2+-activated K+ (BK) channel biophysics and its physiological impact on
specific cells and tissues, highlighting its relationship with auxiliary subunit expression (Contreras
et al., 2013). However, the molecular aspects and role of skeletal muscle BK channel subtypes were
not extensively discussed. One of the scientific programs running in our laboratories is related to
the role of BK channel in native skeletal muscle fibers using patch-clamp in excised patch mode
and molecular biology techniques. Briefly, in skeletal muscle the opening of BK channel triggered
by depolarization and Ca2+ ions increases the duration of the hyperpolarization phase between
bursts of action potentials reducing the firing capability during discharge.
One important aspect concerns the BK channel diversity in the tissues. In fact, the functional
diversity of BK channel is established by the association of the alpha subunit encoded by KCNMA1
gene with auxiliary β1–β4 subunits encoded by KCNMB1–4 genes with the contribution of novel
γ subunits (Contreras et al., 2013; Toro et al., 2014; Torres et al., 2014). In skeletal muscle we
established that the alternative splicing of theKCNMA1/slo1 gene is themainmechanism regulating
BK channel diversity in the muscle phenotypes (Shipston, 2001; Tricarico et al., 2005; Dinardo
et al., 2012). Slow-twitch rat fibers show an elevated expression/activity of BK channel which is
characterized by a low sensitivity to Ca2+ ions and absence of response to BK channel openers such
as acetazolamide (Tricarico et al., 2004, 2005). In contrast, BK channel of fast-twitch rat fibers show
a low expression/activity, high Ca2+ ions sensitivity, and response to drugs (Tricarico et al., 2004,
2005). The analysis of rat slo1 gene at N1 and C1–C6 splice sites found the presence of 5 different
variants in both fast-twitch and slow-twitch muscles, such as e17 in C1, e22, and+29 aa in C2 and
rSlo27 and rSlo0 in C4 (Dinardo et al., 2012). Real time-PCR experiment showed that e22 and rSlo0
variants are markedly expressed in fast-twitch muscle, the rSlo27 is found in the slow twitch muscle
giving rise to different “types” of BK channels (Dinardo et al., 2012).
In skeletal muscle, the different types of BK channel play muscle-specific roles contributing to
the calcium-dependent phenotype determination/adaptation to disuse which is associated with
changes of contractile properties and metabolism. After 3–14 days of muscle immobilization of
the rat, in parallel with the slow-to-fast phenotype transition of the fibers, the BK channel of
slow-twitch fibers acquires properties similar to those of fast-twitch fibers (Tricarico et al., 2005).
Enhanced BK channel current is observed during aging in fast-twitch fibers which are
characterized bymuscle disuse and fast-to slow twitch fibers transition (Tricarico et al., 1997; Pierno
et al., 2014).
Tricarico and Mele BK Channel in Skeletal Muscle
In addition, other than regulating fiber excitability and
muscle phenotype transition during disuse, the BK channel sense
extracellular K+ ion concentration regulating cell remodeling
during hyperkalemia as observed in cell line and in a rat model
of ischemia-reperfusion associated with hyperkalemia (Tricarico
et al., 2002, 2013).
BK channel shows mechanosensitive properties. Stretch force
can indeed induce channel activation without cytoplasmic
Ca2+ and deletion of the Ca2+ bowl sequence diminishes
the channel Ca2+ activation, but leaves the mechanosensitivity
almost intact. Lack of the 59AA sequence known as STREX
in the carboxyterminus domain abolished mechanosensitivity
without altering Ca2+ activation. These evidences suggest that
Ca bowl and STREX domain independently regulate BK channel
activity (Zhao and Sokabe, 2008; Zhao et al., 2010). The
mechanosensitivity of the BK channel may have relevance in
those physiopathological conditions associated with abnormal
channel function such as aging and muscle adaptation to disuse.
The presence of different types of BK channel in skeletal
muscle may have implications for drug-based therapy of
neuromuscular disorders, including hyper/hypokalemic periodic
paralysis (PP). HypoPP is characterized by insulin-induced
paralysis and hypokalemia associated with mutations of SCN5A
and CACNA1 genes, respectively encoding for the voltage-
dependent Na+-channel and Ca2+-channel carrying abnormal
H+/Na+ currents, and down-regulation of inwardly-rectifying
K+-channels (Kir) andATP sensitive K+-channel (KATP) in fast-
twitch muscle (Tricarico et al., 2003a, 2008a; Jovanovic´ et al.,
2008; Tricarico and Camerino, 2011). HyperPP is associated with
gain-of-function mutations of the SCN5A gene with persistent
Na+ influx and depolarization, which in turn inactivates the
Na+-channel and lead to the eﬄux of K+ ions carried by
Kv/BK channels with hyperkalemia and paralysis (Cannon,
2015). KATP/BK channel openers are effective in resolving
the paralytic attacks in Periodic Paralysis (Tricarico et al.,
2003b, 2010; Tricarico and Camerino, 2011). Acetazolamide and
dichlorphenamide act in hypoPP at micromolar concentrations
of opening the BK channel in excised macropatches from
fast-twitch rat fibers and are effective in repolarizing the
fibers in animal models of hypoPP and in hypoPP patients
(Tricarico et al., 2004; Jurkat-Rott et al., 2009; Tricarico and
Camerino, 2011; Imbrici et al., 2016). In addition, acetazolamide
and dichlorphenamide inhibits the membrane bound carbonic
anhydrase enzymes CAIV/XIV and the CAII cytosolic form
with change in the intra/extra cellular [H+]. This affects the
activity of extra/intracellular proton exchange mechanisms. In
our experiments acetazolamide inhibits the monocarboxylate
transporter reducing the eﬄux of lactate thereby preventing
myopathy (Tricarico et al., 2008b; Tricarico and Camerino,
2011). The activity of ion channels showing pH-sensitive gating
may be also affected by acetazolamide and dichlorphenamide. In
this respect, hypoPP patients with the histidine substitutions are
responsive to the drug while those with glycine substitutions are
not alleviated by lowering intracellular pH and have not benefited
by acetazolamide (Tricarico and Camerino, 2011). Clinical
investigation recently showed that dichlorphenamide is effective
in reducing the average number of attacks per week in hypoPP
patient but not in hyperPP (Sansone et al., 2016). Therefore,
dichlorphenamide can be a preferential drug in hypoPP
patients, including those not responsive to acetazolamide, while
acetazolamide is also effective in hyperPP and myotonia. In
conclusion, different factors may affect the drug responses
of acetazolamide and dichlorphenamide in neuromuscular
disorders. Among these, the expression of pH-sensitive mutant
subunits in the muscles can play a role. Alternatively, a particular
combination of BK subunits that include the slo27 may lead
to the formation of BK channel unresponsive to the drugs.
Drugs specifically targeting the slow-type BK channel or the fast-
twitch type may be helpful in disorders affecting specific muscle
phenotype.
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